ZBIO
Zenas BioPharma, Inc.
$28.24
-1.17 (-3.98%)
At close · Jul 16
Going-concern doubt
— cleared May 13, 2026
The latest filing states the doubt was alleviated.
“During the first quarter of 2026, the Company alleviated the uncertainty associated with its ability to continue as a going concern through the execution of its senior secured term loan, the issuance of convertible senior notes and the concurrent equity offering”View the 10-Q filed May 13, 2026
Market Cap
$1.78B
Shares
63,133,377
Stock transactions by members of the U.S. Congress, disclosed under the STOCK Act. Lawmakers must report trades within 45 days, so the filing date can lag the trade itself.
No Congressional Trades
No congressional trading data is available for this stock yet.